Cours CytoDyn Inc. Other OTC
Actions
CYDY
US23283M1018
Recherche biotechnologique et médicale
CA 2022 | 0,27 0,24 | CA 2023 | - | Capitalisation | 239 M 219 M |
---|---|---|---|---|---|
Résultat net 2022 | -211 M -193 M | Résultat net 2023 | -79 M -72,23 M | VE / CA 2022 | 989 524 989 x |
Dette nette 2022 | 32,57 M 29,77 M | Dette nette 2023 | 33,01 M 30,18 M | VE / CA 2023 | - |
PER 2022 |
-1,02
x | PER 2023 |
-2,52
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 99,15% |
Dernier transcript sur CytoDyn Inc.
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 64 | 17/11 | |
Mitchell Cohen
DFI | Director of Finance/CFO | 68 | 01/02 |
Scott Hansen
CTO | Chief Tech/Sci/R&D Officer | - | 03/05/23 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Stephen Simes
BRD | Director/Board Member | 72 | 13/10/22 |
Ryan Dunlap
BRD | Director/Board Member | 54 | 24/08/22 |
Karen Brunke
BRD | Director/Board Member | 72 | 01/04/22 |
Varia. 1 janv. | Capi. | |
---|---|---|
-2,63% | 102 Md | |
+1,62% | 96,29 Md | |
+2,04% | 22,18 Md | |
-16,67% | 21,2 Md | |
-9,79% | 18,31 Md | |
-38,74% | 17,38 Md | |
-13,21% | 16,36 Md | |
+5,41% | 13,97 Md | |
+33,57% | 12,17 Md |